Skip to main content

Table 2 Multivariate regression analysis of factors associated with HCV antiviral therapy

From: Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study

 

Adjusted OR (95% CI)

P-value

Age

0.969 (0.934, 1.005)

0.0892

Gender

  

 Female

1

-

 Male

0.805 (0.346, 1.872)

0.6138

Race

  

 White, non Hispanic

1

-

 African-American, non Hispanic

1.019 (0.399, 2.603)

0.3692

 Hispanic

1.882 (0.671, 5.28)

0.3924

 Other

1.93 (0.515, 7.237)

0.4715

Region

  

 Northeast

1

-

 Midwest

1.734 (0.368, 8.172)

0.6205

 West

0.920 (0.269, 3.144)

0.438

 South

1.857 (0.686, 5.026)

0.277

Insurance

  

 Private Insurance

1

-

 Medicare

3.373 (0.665, 17.097)

0.1527

 Medicaid

2.257 (0.481, 10.592)

0.5098

 Other/unknown

1.300 (0.204, 8.276)

0.4562

 Self-pay

2.440 (0.559, 10.644)

0.4657

 No Charge

1.903 (0.494, 7.335)

0.9823

Depression

0.265 (0.131, 0.536)

0.0002

HIV/HCV Coinfection vs. HCV Monoinfection

  

 2005-2006 (year of visit)

0.5145 (0.148, 1.789)

0.296

 2007-2008 (year of visit)

0.3082 (0.014, 6.943)

0.4589

 2009-2010 (year of visit)

0.3293 (0.039, 2.786)

0.3079